Literature DB >> 11030797

Novel presenilin 1 mutations associated with early onset of dementia in a family with both early-onset and late-onset Alzheimer disease.

G Devi1, A Fotiou, D Jyrinji, B Tycko, S DeArmand, E Rogaeva, Y Q Song, H Medieros, Y Liang, A Orlacchio, J Williamson, P St George-Hyslop, R Mayeux.   

Abstract

Two children of an adult with early-onset, autopsy-confirmed Alzheimer disease (AD) developed dementia in their late 20s and were subsequently found to have novel mutations in codon 434 of the presenilin 1 (PS1) gene on chromosome 14, a G-to-T substitution at nucleotide 1548 and a C-to-G substitution at nucleotide 1549. The younger of the 2 children had AD confirmed at postmortem examination. The disease course in these 3 individuals was characterized by cognitive and behavioral problems accompanied by myoclonus, seizures, and aphasia within 5 years after onset. Two grandparents had clinically diagnosed AD with stroke beginning at ages 78 and 66 years, but neither had a PS1 mutation. No other living family member was demented, nor did any other family member have the PS1 mutation. We conclude that the affected parent of the proband was a likely recent founder for these novel mutations in PS1. The family demonstrates the clinical and genetic heterogeneity of AD. Arch Neurol. 2000;57:1454-1457

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11030797     DOI: 10.1001/archneur.57.10.1454

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  10 in total

Review 1.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

2.  Rare causes of early-onset dystonia-parkinsonism with cognitive impairment: a de novo PSEN-1 mutation.

Authors:  Miryam Carecchio; Marina Picillo; Lorella Valletta; Antonio E Elia; Tobias B Haack; Autilia Cozzolino; Annalisa Vitale; Barbara Garavaglia; Arcangela Iuso; Caterina F Bagella; Sabina Pappatà; Paolo Barone; Holger Prokisch; Luigi Romito; Valeria Tiranti
Journal:  Neurogenetics       Date:  2017-06-29       Impact factor: 2.660

Review 3.  Alzheimer's disease genetics: from the bench to the clinic.

Authors:  Celeste M Karch; Carlos Cruchaga; Alison M Goate
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

4.  Alcadein cleavages by amyloid beta-precursor protein (APP) alpha- and gamma-secretases generate small peptides, p3-Alcs, indicating Alzheimer disease-related gamma-secretase dysfunction.

Authors:  Saori Hata; Sayaka Fujishige; Yoichi Araki; Naoko Kato; Masahiko Araseki; Masaki Nishimura; Dieter Hartmann; Paul Saftig; Falk Fahrenholz; Miyako Taniguchi; Katsuya Urakami; Hiroyasu Akatsu; Ralph N Martins; Kazuo Yamamoto; Masahiro Maeda; Tohru Yamamoto; Tadashi Nakaya; Sam Gandy; Toshiharu Suzuki
Journal:  J Biol Chem       Date:  2009-10-28       Impact factor: 5.157

5.  The usefulness of biological and neuroimaging markers for the diagnosis of early-onset Alzheimer's disease.

Authors:  Alessandro Padovani; Nicola Gilberti; Barbara Borroni
Journal:  Int J Alzheimers Dis       Date:  2011-02-21

6.  Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families.

Authors:  Carlos Cruchaga; Gabe Haller; Sumitra Chakraverty; Kevin Mayo; Francesco L M Vallania; Robi D Mitra; Kelley Faber; Jennifer Williamson; Tom Bird; Ramon Diaz-Arrastia; Tatiana M Foroud; Bradley F Boeve; Neill R Graff-Radford; Pamela St Jean; Michael Lawson; Margaret G Ehm; Richard Mayeux; Alison M Goate
Journal:  PLoS One       Date:  2012-02-01       Impact factor: 3.240

Review 7.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682

8.  Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.

Authors:  Maria Victoria Fernández; Jong Hun Kim; John P Budde; Kathleen Black; Alexandra Medvedeva; Ben Saef; Yuetiva Deming; Jorge Del-Aguila; Laura Ibañez; Umber Dube; Oscar Harari; Joanne Norton; Rachel Chasse; John C Morris; Alison Goate; Carlos Cruchaga
Journal:  PLoS Genet       Date:  2017-11-01       Impact factor: 5.917

Review 9.  A key role for MAM in mediating mitochondrial dysfunction in Alzheimer disease.

Authors:  Estela Area-Gomez; Ad de Groof; Eduardo Bonilla; Jorge Montesinos; Kurenai Tanji; Istvan Boldogh; Liza Pon; Eric A Schon
Journal:  Cell Death Dis       Date:  2018-02-28       Impact factor: 8.469

10.  Identification of biomarkers of human skin ageing in both genders. Wnt signalling - a label of skin ageing?

Authors:  Evgenia Makrantonaki; Thore C Brink; Vasiliki Zampeli; Rana Mohsen Elewa; Barbara Mlody; Amir M Hossini; Bjoern Hermes; Ulf Krause; Juergen Knolle; Marwa Abdallah; James Adjaye; Christos C Zouboulis
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.